BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27704404)

  • 21. Weight uniformity of split tablets required by a Veterans Affairs policy.
    Polli JE; Kim S; Martin BR
    J Manag Care Pharm; 2003; 9(5):401-7. PubMed ID: 14613437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tablet splitting: a review of weight and content uniformity.
    Freeman MK; White W; Iranikhah M
    Consult Pharm; 2012 May; 27(5):341-52. PubMed ID: 22591978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-release formulations for the treatment of epilepsy.
    Bialer M
    CNS Drugs; 2007; 21(9):765-74. PubMed ID: 17696575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of tablet splitting and liquid measurements: an examination of who, what and how.
    Abu-Geras D; Hadziomerovic D; Leau A; Khan RN; Gudka S; Locher C; Razaghikashani M; Lim LY
    J Pharm Pharmacol; 2017 May; 69(5):603-612. PubMed ID: 28028813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
    Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
    J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.
    Chou CL; Hsu CC; Chou CY; Chen TJ; Chou LF; Chou YC
    Int J Clin Pharm; 2015 Dec; 37(6):1235-41. PubMed ID: 26399507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
    Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ
    Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.
    Cho YS; Ah YM; Jung AH; Kim KJ; Lee JY
    Paediatr Drugs; 2015 Dec; 17(6):487-96. PubMed ID: 26400586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperhomocysteinaemia in children receiving phenytoin and carbamazepine monotherapy: a cross-sectional observational study.
    Chandrasekaran S; Patil S; Suthar R; Attri SV; Sahu JK; Sankhyan N; Tageja M; Singhi P
    Arch Dis Child; 2017 Apr; 102(4):346-351. PubMed ID: 27821519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Schoemaker R; Wade JR; Stockis A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):727-733. PubMed ID: 28280887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight uniformity of scored tablet halves manufactured by palestinian pharmaceutical companies.
    Zaid AN; Abu GA; Kittana N
    Int J Pharm Compd; 2010; 14(3):257-60. PubMed ID: 23965504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic ranges of anti-epileptic drugs in monotherapy of children].
    Armijo Simón JA; Herranz Fernández JL; Valiente Domingo R; Arteaga Manjón-Cabeza R
    An Esp Pediatr; 1991 Jan; 34(1):32-42. PubMed ID: 2018256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman.
    Al Za'abi M; Ahmed R; Al Asmi A; Al-Zakwani I
    Int J Pharm Pract; 2013 Apr; 21(2):117-22. PubMed ID: 23418868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database.
    Nicholas JM; Ridsdale L; Richardson MP; Ashworth M; Gulliford MC
    Seizure; 2012 Jul; 21(6):466-70. PubMed ID: 22608976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
    Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
    Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.